Daniel Lantigua

Mr. Daniel Lantigua


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
AFAmir Mohammad Karimi Forood
Amir Mohammad Karimi Forood
SPSibi Pandian
Sibi Pandian
RMRiley Quinn McNaboe
Riley Quinn McNaboe
TLThuany De Carvalho Lachos
Thuany De Carvalho Lachos
DLDaniel Lantigua
Daniel Lantigua
Hugo Fernando Posada-QuinteroHugo Fernando Posada-Quintero
Hugo Fernando Posada-Quintero
Visceral pain in Irritable Bowel Syndrome (IBS) is difficult to evaluate objectively due to its complex physiological nature and lack of reliable biomarkers. Given the complexity of IBS, a multimodal physiological monitoring approach, combining electrodermal activity (EDA), electrocardiogram (ECG), and surface electromyography (sEMG), offers a promising approach to capture the autonomic and muscular responses linked to visceral pain. However, no existing wearable device supports simultaneous EDA, ECG, and sEMG acquisition from the abdomen in a format suitable for long-term, real-world use. This study presents the development and validation of a novel wearable belt for concurrent ECG, sEMG, and EDA monitoring, with EDA measured at both the torso and wrist. The system was built using modified BITalino platforms with custom-fabricated reusable electrodes and Bluetooth connectivity for real-time smartphone display. Signal quality was validated against laboratory-grade systems in 20 healthy participants during a four-stage protocol involving cognitive, orthostatic, muscular, and combined stress tasks. Time and frequency-domain analyses showed high correlations and comparable spectral features across all modalities. The belt maintained stable skin contact even during movement-intensive tasks. By enabling anatomically targeted, multimodal data acquisition, this wearable system supports real-world visceral pain assessment in IBS and is ready for deployment in ambulatory and home-based monitoring scenarios.